Novel growth hormone receptor antagonist with discrete PEGylations markedly improve response to therapy in human pancreatic and bile duct cancers in mice

被引:1
|
作者
Basu, Reetobrata
Kopchick, John J.
机构
关键词
D O I
10.1158/1538-7445.AM2023-408
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
408
引用
收藏
页数:2
相关论文
共 39 条
  • [1] Growth Hormone Receptor Antagonist Markedly Improves Gemcitabine Response in a Mouse Xenograft Model of Human Pancreatic Cancer
    Basu, Reetobrata
    Kulkarni, Prateek
    Swegan, Deborah
    Duran-Ortiz, Silvana
    Ahmad, Arshad
    Caggiano, Lydia J.
    Davis, Emily
    Walsh, Christopher
    Brenya, Edward
    Koshal, Adeel
    Brody, Rich
    Sandbhor, Uday
    Neggers, Sebastian J. C. M. M.
    Kopchick, John J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [2] A novel peptide antagonist of the human growth hormone receptor
    Basu, Reetobrata
    Nahar, Khairun
    Kulkarni, Prateek
    Kerekes, Olivia
    Sattler, Maya
    Hall, Zachary
    Neggers, Sebastian
    Holub, Justin M.
    Kopchick, John J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
  • [3] A novel peptide-based antagonist of the human growth hormone receptor
    Holub, Justin M.
    JOURNAL OF PEPTIDE SCIENCE, 2022, 28
  • [4] Growth hormone receptor antagonist administration inhibits growth of human colorectal carcinoma in nude mice
    Dagnaes-Hansen, F
    Duan, H
    Rasmussen, LM
    Friend, KE
    Flyvbjerg, A
    ANTICANCER RESEARCH, 2004, 24 (06) : 3735 - 3742
  • [5] Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice
    McCutcheon, IE
    Flyvbjerg, A
    Hill, H
    Li, J
    Bennett, WF
    Scarlett, JA
    Friend, KE
    JOURNAL OF NEUROSURGERY, 2001, 94 (03) : 487 - 492
  • [6] Combination of antagonists of growth hormone-releasing hormone antagonist (GHRH) with rapamycin as a potential therapy in human breast cancers.
    Buchholz, S.
    Weber, F.
    Schally, A.
    Ortmann, O.
    Seitz, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Common Bile Duct Injection as a Novel Method for Establishing Red Fluorescent Protein (RFP)-Expressing Human Pancreatic Cancer in Nude Mice
    Tsuji, Kazuhiko
    Yang, Meng
    Jiang, Ping
    Maitra, Anirban
    Kaushal, Sharmeela
    Yamauchi, Kensuke
    Katz, Matthew H.
    Moossa, Abdool R.
    Hoffman, Robert M.
    Bouvet, Michael
    JOURNAL OF THE PANCREAS, 2006, 7 (02): : 193 - 199
  • [8] A POTENT CCK RECEPTOR ANTAGONIST (L-364,718) INHIBITS THE GROWTH OF HUMAN PANCREATIC-CANCER IN NUDE-MICE
    MAANI, R
    TOWNSEND, CM
    GOMEZ, G
    THOMPSON, JC
    SINGH, P
    GASTROENTEROLOGY, 1988, 94 (05) : A274 - A274
  • [9] GROWTH-INHIBITION OF HUMAN PANCREATIC-CANCER CELLS BY CHOLECYSTOKININ RECEPTOR ANTAGONIST IN TISSUE-CULTURE AND IN NUDE-MICE
    FUNAKOSHI, A
    KONO, A
    GASTROENTEROLOGIA JAPONICA, 1992, 27 (01): : 78 - 82
  • [10] Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers
    Ilenia Migliaccio
    Luca Malorni
    Christopher D Hart
    Cristina Guarducci
    Angelo Di Leo
    BMC Medicine, 13